Newsfeeds - Spark Newswire

1 minute read

News

Evolent Health Announces Acquisition Of Specialty Asset Nia And Strategic Partnership With Centene

Today, 2:16 AM

Accelerates Evolent Health's Value-Based Specialty Care Market Leadership Transaction Anticipated to be Immediately Accretive to Adjusted EBITDA Margins and Cash Flow Highly Complementary Business Expected to

CNC

1 minute read

Analyst Ratings

What 7 Analyst Ratings Have To Say About Evolent Health

By Benzinga Insights

Today, 2:16 AM

Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings:

EVH

1 minute read

Canaccord Genuity Maintains Buy on Evolent Health, Lowers Price Target to $48

By Benzinga Newsdesk

Today, 2:16 AM

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $55 to $48.

EVH

1 minute read

BTIG Maintains Buy on Evolent Health, Lowers Price Target to $45

By Benzinga Newsdesk

Today, 2:16 AM

BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $55 to $45.

EVH

1 minute read

Analyst Ratings

Expert Ratings for Evolent Health

By Benzinga Insights

Today, 2:16 AM

Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter:

EVH

1 minute read

JP Morgan Maintains Overweight on Evolent Health, Raises Price Target to $52

By Benzinga Newsdesk

Today, 2:16 AM

JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $37 to $52.

EVH

1 minute read

RBC Capital Maintains Outperform on Evolent Health, Raises Price Target to $44

By Benzinga Newsdesk

Today, 2:16 AM

RBC Capital analyst Sean Dodge maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $40 to $44.

EVH

1 minute read

BTIG Maintains Buy on Evolent Health, Raises Price Target to $50

By Benzinga Newsdesk

Today, 2:16 AM

BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $45 to $50.

EVH

1 minute read

Piper Sandler Maintains Overweight on Evolent Health, Raises Price Target to $40

By Benzinga Newsdesk

Today, 2:16 AM

Piper Sandler analyst Jessica Tassan maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $35 to $40.

EVH

17 minute read

Earnings Scheduled For August 2, 2022

By Benzinga Insights

Today, 2:16 AM

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

ABNB